γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation
Abstract We here defined the impacts of γ-secretase inhibitors (GSIs) on T-cell-dependent BCMA-specific multiple myeloma (MM) cell lysis and immunomodulatory effects induced by bispecific antibodies (BisAbs). GSIs-induced membrane BCMA (mBCMA) accumulation reached near maximum within 4 h and sustain...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Publishing Group
2022-08-01
|
| Reeks: | Blood Cancer Journal |
| Online toegang: | https://doi.org/10.1038/s41408-022-00716-3 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
